I 

111TH CONGRESS 

1ST SESSION H. R. 3069 

To direct the Secretary of Health and Human Services to conduct or support 

a comprehensive study comparing total health outcomes, including risk 

of autism, in vaccinated populations in the United States with such 

outcomes in unvaccinated populations in the United States, and for 

other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 26, 2009 

Mrs. MALONEY (for herself, Mr. SMITH of New Jersey, Mr. GORDON of Tennessee, Mr. BURTON of Indiana, Mr. LANGEVIN, Ms. GINNY BROWNWAITE of Florida, Mrs. NAPOLITANO, and Mr. KENNEDY) introduced the 

following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To direct the Secretary of Health and Human Services to 

conduct or support a comprehensive study comparing 

total health outcomes, including risk of autism, in vaccinated populations in the United States with such outcomes in unvaccinated populations in the United States, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


wwoods2 on PRODPC68 with BILLS
2 

•HR 3069 IH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Comprehensive Com3 parative Study of Vaccinated and Unvaccinated Popu4 lations Act of 2009’’. 

5 SEC. 2. FINDINGS. 

6 The Congress finds as follows: 

7 (1) Securing the health of the Nation’s children 

8 is our most important concern as parents and stew9 ards of the Nation’s future. 

10 (2) The Nation’s vaccine program has greatly 

11 reduced human suffering from infectious disease by 

12 preventing and reducing the outbreak of vaccine-pre13 ventable diseases. 

14 (3) Total health outcomes are the best measure 

15 of the success of any public health effort, including 

16 security from both chronic and infectious disease. 

17 (4) Childhood immunizations are an important 

18 tool in the pursuit of childhood health. 

19 (5) The number of immunizations administered 

20 to infants, pregnant women, children, teenagers, and 

21 adults has grown dramatically over recent years. 

22 (6) The incidence of chronic, unexplained dis23 eases such as autism, learning disabilities, and other 

24 neurological disorders appears to have increased dra25 matically in recent years. 


wwoods2 on PRODPC68 with BILLS
3 

•HR 3069 IH

1 (7) Individual vaccines are tested for safety, but 

2 little safety testing has been conducted for inter3 action effects of multiple vaccines. 

4 (8) The strategy of aggressive, early childhood 

5 immunization against a large number of infectious 

6 diseases has never been tested in its entirety against 

7 alternative strategies, either for safety or for total 

8 health outcomes. 

9 (9) Childhood immunizations are the only 

10 health interventions that are required by States of 

11 all citizens in order to participate in civic society. 

12 (10) Public confidence in the management of 

13 public health can only be maintained if these State 

14 government-mandated, mass vaccination programs— 

15 (A) are tested rigorously and in their en16 tirety against all reasonable safety concerns; 

17 and 

18 (B) are verified in their entirety to produce 

19 superior health outcomes. 

20 (11) There are numerous United States popu21 lations in which a practice of no vaccination is fol22 lowed and which therefore provide a natural com23 parison group for comparing total health outcomes. 

24 (12) No comparative study of such health out25 comes has ever been conducted. 


wwoods2 on PRODPC68 with BILLS
4 

•HR 3069 IH

1 (13) Given rising concern over the high rates of 

2 childhood neurodevelopmental disorders such as au3 tism, the need for such studies is becoming urgent. 

4 SEC. 3. STUDY ON HEALTH OUTCOMES IN VACCINATED 

5 AND UNVACCINATED AMERICAN POPU6 LATIONS. 

7 (a) IN GENERAL.—The Secretary of Health and 

8 Human Services (in this Act referred to as the ‘‘Sec9 retary’’), acting through the Director of the National In10 stitutes of Health, shall conduct or support a comprehen11 sive study— 

12 (1) to compare total health outcomes, including 

13 risk of autism, in vaccinated populations in the 

14 United States with such outcomes in unvaccinated 

15 populations in the United States; and 

16 (2) to determine whether vaccines or vaccine 

17 components play a role in the development of autism 

18 spectrum or other neurological conditions. 

19 (b) QUALIFICATIONS.—With respect to each investi20 gator carrying out the study under this section, the Sec21 retary shall ensure that the investigator— 

22 (1) is objective; 

23 (2) is qualified to carry out such study, as evi24 denced by training experiences and demonstrated 

25 skill; 


wwoods2 on PRODPC68 with BILLS
5 

•HR 3069 IH

1 (3) is not currently employed by any Federal, 

2 State, or local public health agency; 

3 (4) is not currently a member of a board, com4 mittee, or other entity responsible for formulating 

5 immunization policy on behalf of any Federal, State, 

6 or local public health agency or any component 

7 thereof; 

8 (5) has no history of a strong position on the 

9 thimerosal controversy; and 

10 (6) is not currently an employee of, or other11 wise directly or indirectly receiving funds from, a 

12 pharmaceutical company. 

13 (c) TARGET POPULATIONS.—The Secretary shall 

14 seek to include in the study under this section populations 

15 in the United States that have traditionally remained 

16 unvaccinated for religious or other reasons, such as Old 

17 Order Amish, members of clinical practices (such as the 

18 Homefirst practice in Chicago) who choose alternative 

19 medical practices, and practitioners of anthroposophic life20 styles. 

21 (d) TIMING.—Not later than 120 days after the date 

22 of the enactment of this Act, the Secretary shall issue a 

23 request for proposals to conduct the study required by this 

24 section. Not later than 120 days after receipt of any such 

25 proposal, the Secretary shall approve or disapprove the 


wwoods2 on PRODPC68 with BILLS
6 

•HR 3069 IH

1 proposal. If the Secretary disapproves the proposal, the 

2 Secretary shall provide the applicant involved with a writ3 ten explanation of the reasons for the disapproval. 

Æ 


wwoods2 on PRODPC68 with BILLS